Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer
/in Dendritic Cells, International Publications, NSCLC /von 2014-09-28 / Cancer Immunol. Immunother. 2015 Jan;64(1):51-9Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy
/in International Publications, Newcastle Disease Virus /von 2014-09-26 / Cancer Gene Ther. 2014 Nov;21(11):463-71Thermotolerance induced at a mild temperature of 40°C alleviates heat shock-induced ER stress and apoptosis in HeLa cells
/in Hyperthermia, International Publications /von 2014-09-26 / Biochim. Biophys. Acta 2015 Jan;1853(1):52-62Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review
/in Glioblastoma, International Publications /von 2014-09-26 / Cancer Invest. 2014 Nov;32(9):451-7MiR-630 inhibits proliferation by targeting CDC7 kinase, but maintains the apoptotic balance by targeting multiple modulators in human lung cancer A549 cells
/in Glioblastoma, International Publications /von 2014-09-25 / Cell Death Dis 2014 Sep;5:e1426Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-09-25 / Oncol Lett 2014 Dec;8(6):2569-2576Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response
/in Dendritic Cells, Hypernephroma, International Publications, Malignant Melanoma /von 2014-09-23 / J Transl Med 2014 Sep;12:262Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
/in Glioblastoma, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2014-09-19 / Int J Cancer 2015 Mar;136(5):E313-25Modulated electro-hyperthermia enhances dendritic cell therapy through an abscopal effect in mice
/in Hyperthermia, International Publications /von 2014-09-19 / Oncol. Rep. 2014 Dec;32(6):2373-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution